Literature DB >> 12095399

Increased nitric oxide elimination from the airways after smoking cessation.

M Högman1, T Holmkvist, R Wålinder, P Meriläinen, D Lúdvíksdóttir, L Håkansson, H Hedenström.   

Abstract

Smokers have been found to have low exhaled nitric oxide (NO) levels. The aim of the present study was to investigate where in the respiratory system the decrease in NO occurs, and whether this decrease was affected by smoking cessation. Measurements of exhaled NO were carried out in smokers (n=20) and non-smoking control subjects (n=30). In nine of the smokers, exhaled NO was analysed 1, 2 and 4 weeks after smoking cessation. The level of exhaled NO at a flow rate of 0.1 litre/s was significantly lower in smokers (4+/-2 p.p.b.) than in non-smokers (7+/-5 p.p.b.; P=0.007). A calculation of the contributions from different areas of the lung showed that the NO flux from the airways was significantly lower (14+/-10 compared with 36+/-26 nl/min; P=0.0001) and the alveolar fraction was significantly higher (2.1+/-0.8 compared with 1.5+/-0.9 p.p.b.; P=0.006) in smokers than in non-smokers. Nine smoking subjects refrained from smoking for 4 weeks, and this resulted in increased NO flux from the airways of 28+/-17 nl/min, which was no longer significantly different from controls. In conclusion, endogenous production of NO in the airways is decreased in smokers, but can be restored to normal values by 4 weeks after cessation of smoking. Smokers have an increased alveolar fraction of NO, and this might be a diagnostic sign of lung damage. Thus NO monitoring can be used to indicate improvements when a smoker decides to stop smoking.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095399     DOI: 10.1042/cs1030015

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  14 in total

Review 1.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

Review 2.  A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.

Authors:  Peter G Shields; Micah Berman; Theodore M Brasky; Jo L Freudenheim; Ewy Mathe; Joseph P McElroy; Min-Ae Song; Mark D Wewers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-22       Impact factor: 4.254

3.  Effect of Nicotine on STAT1 Pathway and Oxidative Stress in Rat Lungs.

Authors:  Aida Abdeen Mahmoud; Hekmat Osman Abdel-Aziz; Mohamed Elbadr; Hala Elbadre
Journal:  Rep Biochem Mol Biol       Date:  2021-10

Review 4.  Partitioned exhaled nitric oxide to non-invasively assess asthma.

Authors:  James L Puckett; Steven C George
Journal:  Respir Physiol Neurobiol       Date:  2008-07-31       Impact factor: 1.931

5.  Modulation of Lung Function by Increased Nitric Oxide Production.

Authors:  Md Nazrul Islam; Ram Lochan Yadav; Prakash Kumar Yadav
Journal:  J Clin Diagn Res       Date:  2017-06-01

6.  Recent Marijuana Use and Associations With Exhaled Nitric Oxide and Pulmonary Function in Adults in the United States.

Authors:  Stefania I Papatheodorou; Hannah Buettner; Mary B Rice; Murray A Mittleman
Journal:  Chest       Date:  2016-01-16       Impact factor: 9.410

7.  Exhaled nitric oxide in early rheumatoid arthritis and effects of methotrexate treatment.

Authors:  Tomas Weitoft; Anders Lind; Anders Larsson; Johan Rönnelid; Marieann Högman
Journal:  Sci Rep       Date:  2022-04-20       Impact factor: 4.996

8.  Effect of nanoparticles exposure on fractional exhaled nitric oxide (FENO) in workers exposed to nanomaterials.

Authors:  Wei-Te Wu; Hui-Yi Liao; Yu-Teh Chung; Wan-Fen Li; Tsui-Chun Tsou; Lih-Ann Li; Ming-Hsiu Lin; Jiune-Jye Ho; Trong-Neng Wu; Saou-Hsing Liou
Journal:  Int J Mol Sci       Date:  2014-01-09       Impact factor: 5.923

9.  Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes.

Authors:  Carl D D'Ruiz; Donald W Graff; Edward Robinson
Journal:  BMC Public Health       Date:  2016-07-11       Impact factor: 3.295

10.  Exhaled and nasal nitric oxide in laryngectomized patients.

Authors:  Matthias F Kramer; Bernhard Olzowy; Annette Bihler; Dorothea de la Motte; Dennis Nowak; Rudolf A Jörres; Holger Dressel
Journal:  BMC Pulm Med       Date:  2010-01-28       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.